Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence.
Saved in:
| Title: | Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence. |
|---|---|
| Authors: | Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA., Zhao R; Taiho Oncology, Inc, Princeton, NJ, USA., Epstein RS; Epstein Health, Woodcliff Lake, NJ, USA., Salimi T; Taiho Oncology, Inc, Princeton, NJ, USA. |
| Source: | Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2025 Nov; Vol. 25 (11), pp. 1243-1250. Date of Electronic Publication: 2025 Aug 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40770939 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zeidan+AM%22">Zeidan AM</searchLink>; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+R%22">Zhao R</searchLink>; Taiho Oncology, Inc, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Epstein+RS%22">Epstein RS</searchLink>; Epstein Health, Woodcliff Lake, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Salimi+T%22">Salimi T</searchLink>; Taiho Oncology, Inc, Princeton, NJ, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101123358%22">Expert review of anticancer therapy</searchLink> [Expert Rev Anticancer Ther] 2025 Nov; Vol. 25 (11), pp. 1243-1250. <i>Date of Electronic Publication: </i>2025 Aug 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101123358 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8328 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737140%22">14737140 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Anticancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40770939 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/14737140.2025.2544859 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1243 Titles: – TitleFull: Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidence. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zeidan AM – PersonEntity: Name: NameFull: Zhao R – PersonEntity: Name: NameFull: Epstein RS – PersonEntity: Name: NameFull: Salimi T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1744-8328 Numbering: – Type: volume Value: 25 – Type: issue Value: 11 Titles: – TitleFull: Expert review of anticancer therapy Type: main |
| ResultId | 1 |
